logoTry Persana

Calico Life Sciences - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Calico Life Sciences including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Calico Life Sciences company logo

We're tackling aging, one of life's greatest mysteries

Calico Life Sciences is a research and development company founded by Alphabet with a mission to harness advanced technologies to understand the biology controlling human aging and to develop interventions for age-related diseases.

HeadquartersSouth San Francisco, United States
Team size201-500
Founded2013

What is Calico Life Sciences? - Company Overview & Details

Calico Life Sciences is Calico Life Sciences is a research and development company founded by Alphabet with a mission to harness advanced technologies to understand the biology controlling human aging and to develop interventions for age-related diseases. Founded in 2013, the company is headquartered in South San Francisco, United States.

Who Founded Calico Life Sciences?

Calico Life Sciences was founded by Arthur Levinson.

Who are the Key Executives at Calico Life Sciences? - Leadership Team

Calico Life Sciences is led by experienced executives in key positions:

Calico Life Sciences Company Details & Key Information

Where is Calico Life Sciences located?

Calico Life Sciences is headquartered in South San Francisco, United States.

How many employees does Calico Life Sciences have?

Calico Life Sciences has 201-500 employees.

When was Calico Life Sciences founded?

Calico Life Sciences was founded in 2013.

How much funding has Calico Life Sciences raised?

Calico Life Sciences has raised $1.5 Billion across 1 funding rounds. The most recent funding was completed on 2021-02-01.

Funding Overview

Calico has received extensive funding, primarily from Alphabet, to investigate the biology of aging through innovative research.

$1.5 Billion
Total Funding Raised
1
Funding Rounds
2021-02-01
Latest Round

Calico Life Sciences Funding History

Seed
2021-02-01
$25 million

Who are the key investors in Calico Life Sciences?

Calico Life Sciences is backed by 1 key investors including Google/Alphabet. These investors focus on Biotechnology, Life Sciences sectors.

Calico Life Sciences Investor Overview

1
Key Investors
2
Focus Areas
1
Notable Investments

Complete List of Calico Life Sciences Investors

Google/Alphabet

Google's parent company, known for its investments in biotechnological advancements.

Investment Focus
Biotechnology
Life Sciences
Notable Portfolio Companies
Calico Life Sciences

What sectors do Calico Life Sciences investors focus on?

The investors backing Calico Life Sciences primarily focus on Biotechnology, Life Sciences sectors.

Biotechnology
Life Sciences

Featured Investor: Google/Alphabet

Google/Alphabet

Google's parent company, known for its investments in biotechnological advancements.

Notable Investments: Calico Life Sciences

What are Calico Life Sciences's future plans?

Calico Life Sciences To expand their pipeline and develop therapeutics addressing the biological mechanisms of aging.

Calico Life Sciences Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Calico Life Sciences face?

Calico Life Sciences has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Calico Life Sciences

1

Translating aging research into effective therapeutics

2

Complex challenges of clinical trials

What opportunities does Calico Life Sciences have?

Calico Life Sciences has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Calico Life Sciences

1

Collaboration with institutions like AbbVie and the Broad Institute

2

Exploring novel solutions to age-related diseases

Calico Life Sciences Strategic Position Summary

Key Focus Areas

Calico Life Sciences is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Calico Life Sciences?

Calico Life Sciences has 2 recent news updates covering key business developments and market activities.

Calico Life Sciences News Overview

2
Recent Articles
Active
Media Coverage
2025-06-30
Latest Update

What is Calico Life Sciences in the news for?

Calico Life Sciences is currently featured in news for Calico Labs partners with Mabwell (Shanghai) Bioscience Co., Ltd.. and other significant business developments.

Recent News Articles About Calico Life Sciences

Article 1
2025-06-30

Calico Labs partners with Mabwell (Shanghai) Bioscience Co., Ltd..

Calico inks a $596m deal for drugs targeting longevity-linked cytokine, signing a licensing agreement with Mabwell Bioscience.

longevity.technology
Read News
Article 2
2025-06-26

Calico Labs is developing 9MW3811 in all regions except greater China.

Calico Life Sciences signs a licensing deal worth up to $571 million for investigational IL-11 directed therapeutics from Mabwell.

fiercebiotech.com
Read News

Calico Life Sciences FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Calico Life Sciences including information about founders, CEO, funding history, investors, headquarters location, and company details. 15 frequently asked questions covering key information about the company.

Calico Life Sciences Questions & Answers - Company Information

Q1

What is Calico Life Sciences?

Calico Life Sciences is a research and development company founded by Alphabet with a mission to harness advanced technologies to understand the biology controlling human aging and to develop interventions for age-related diseases.

Q2

Who founded Calico Life Sciences?

Calico Life Sciences was founded by Arthur Levinson.

Q3

How much funding has Calico Life Sciences raised?

Calico Life Sciences has raised a total of $$1.5 Billion across 1 funding rounds. The most recent funding was completed on 2021-02-01.

Q4

Who are the investors in Calico Life Sciences?

Calico Life Sciences's key investors include Google/Alphabet.

Q5

Where is Calico Life Sciences headquartered?

Calico Life Sciences is headquartered in South San Francisco, United States.

Q6

When was Calico Life Sciences founded?

Calico Life Sciences was founded in 2013.

Q7

How many employees does Calico Life Sciences have?

Calico Life Sciences has 201-500 employees.

Q8

What was Calico Life Sciences's latest funding round?

Calico Life Sciences's latest funding round was a Seed round of $$25 million completed on 2021-02-01.

Q9

What does the company do?

Calico Life Sciences focuses on aging research and treatments aimed at age-related diseases.

Q10

How much funding?

$1.5 Billion

Q11

Latest funding date?

2021-02-01

Q12

Who are the investors?

Google/Alphabet

Q13

What are the challenges?

Translating aging research into effective therapeutics Complex challenges of clinical trials

Q14

What are the opportunities?

Collaboration with institutions like AbbVie and the Broad Institute Exploring novel solutions to age-related diseases

Q15

Latest news?

Calico inks a $596m deal for drugs targeting longevity-linked cytokine, signing a licensing agreement with Mabwell Bioscience. Calico Life Sciences signs a licensing deal worth up to $571 million for investigational IL-11 directed therapeutics from Mabwell.

More Information About Calico Life Sciences

For additional details about Calico Life Sciences, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.